Trial Profile
Efficacy and safety of rFVIIa (NovoSeven) in patients with in acquired haemophilia A by analysis of 10-year Japanese postmarketing surveillance data
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Apr 2017
Price :
$35
*
At a glance
- Drugs Eptacog alfa (Primary)
- Indications Haemophilia A
- Focus Adverse reactions; Therapeutic Use
- 04 Apr 2017 New trial record